Orchard Therapeutics has chosen Fremont, Calif., as the new site to build out a 150,000-square-foot facility for gene therapy manufacturing. The facility will support Orchard's expanded pipeline plans to supply products to be used in its ex vivo gene therapy programs.
Orchard's new gene therapy facility to be in Fremont, Calif.
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.